According to our data, the correlation of HER2 overexpression and Lauren classification was not statistically significant, however, as expected, was consistent with the previous reports stating that a positive expression of HER2 was more frequent in the intestinal type of gastric cancer (22.22%) than in the diffuse-type gastric carcinoma (14.63%). The gene discussed is ERBB2; the disease is gastric cancer.